These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 16278525)

  • 1. Pathophysiologic, diagnostic, and therapeutic aspects of the metabolic syndrome.
    Giles TD; Sander GE
    J Clin Hypertens (Greenwich); 2005 Nov; 7(11):669-78. PubMed ID: 16278525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment principles for the metabolic syndrome].
    Boulogne A; Vantyghem MC
    Presse Med; 2004 Jun; 33(10):673-81. PubMed ID: 15257242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addressing the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome in the southeastern United States, part II: treatment recommendations for management of the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome.
    Bestermann W; Houston MC; Basile J; Egan B; Ferrario CM; Lackland D; Hawkins RG; Reed J; Rogers P; Wise D; Moore MA
    Am J Med Sci; 2005 Jun; 329(6):292-305. PubMed ID: 15958871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
    Nesto RW
    Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic syndrome: contributing factors and treatment strategies.
    Fowler SB; Moussouttas M; Mancini B
    J Neurosci Nurs; 2005 Aug; 37(4):220-3. PubMed ID: 16206549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Metabolic syndrome].
    Boursier V
    J Mal Vasc; 2006 Sep; 31(4 Pt 1):190-201. PubMed ID: 17088787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A truly deadly quartet: obesity, hypertension, hypertriglyceridemia, and hyperinsulinemia.
    Nambi V; Hoogwerf BJ; Sprecher DL
    Cleve Clin J Med; 2002 Dec; 69(12):985-9. PubMed ID: 12546271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome.
    Glueck CJ; Papanna R; Wang P; Goldenberg N; Sieve-Smith L
    Metabolism; 2003 Jul; 52(7):908-15. PubMed ID: 12870169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful control of dyslipidemia in patients with metabolic syndrome: focus on lifestyle changes.
    Stone NJ
    Clin Cornerstone; 2006; 8 Suppl 1():S15-20. PubMed ID: 16903165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metabolic syndrome: diagnosis and treatment.
    Zieve FJ
    Clin Cornerstone; 2004; 6 Suppl 3():S5-13. PubMed ID: 15707265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapeutic options for metabolic syndrome in obese patients].
    Carella AM; Conte M
    Clin Ter; 2007; 158(5):457-64. PubMed ID: 18062354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dyslipidemia in the metabolic syndrome in children.
    Gidding SS
    J Cardiometab Syndr; 2006; 1(4):282-5. PubMed ID: 17679808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematization of clinical trials related to treatment of metabolic syndrome, 1980-2015.
    Cardona Velásquez S; Guzmán Vivares L; Cardona-Arias JA
    Endocrinol Diabetes Nutr; 2017 Feb; 64(2):82-91. PubMed ID: 28440782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of metabolic syndrome.
    Wagh A; Stone NJ
    Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):213-28. PubMed ID: 15151470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial.
    Orchard TJ; Temprosa M; Goldberg R; Haffner S; Ratner R; Marcovina S; Fowler S;
    Ann Intern Med; 2005 Apr; 142(8):611-9. PubMed ID: 15838067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pioglitazone treatment in type 2 diabetes mellitus when combined with portion control diet modifies the metabolic syndrome.
    Gupta AK; Smith SR; Greenway FL; Bray GA
    Diabetes Obes Metab; 2009 Apr; 11(4):330-7. PubMed ID: 19267711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a Lifestyle Intervention Program With Energy-Restricted Mediterranean Diet and Exercise on Weight Loss and Cardiovascular Risk Factors: One-Year Results of the PREDIMED-Plus Trial.
    Salas-Salvadó J; Díaz-López A; Ruiz-Canela M; Basora J; Fitó M; Corella D; Serra-Majem L; Wärnberg J; Romaguera D; Estruch R; Vidal J; Martínez JA; Arós F; Vázquez C; Ros E; Vioque J; López-Miranda J; Bueno-Cavanillas A; Tur JA; Tinahones FJ; Martín V; Lapetra J; Pintó X; Daimiel L; Delgado-Rodríguez M; Matía P; Gómez-Gracia E; Díez-Espino J; Babio N; Castañer O; Sorlí JV; Fiol M; Zulet MÁ; Bulló M; Goday A; Martínez-González MÁ;
    Diabetes Care; 2019 May; 42(5):777-788. PubMed ID: 30389673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of hypertension in children and adolescents with the metabolic syndrome.
    Puri M; Flynn JT
    J Cardiometab Syndr; 2006; 1(4):259-68. PubMed ID: 17679805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing atherosclerosis in patients with type 2 diabetes mellitus and metabolic syndrome.
    Venkatapuram S; Shannon RP
    Am J Ther; 2006; 13(1):64-71. PubMed ID: 16428924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertriglyceridemia, insulin resistance, and the metabolic syndrome.
    Grundy SM
    Am J Cardiol; 1999 May; 83(9B):25F-29F. PubMed ID: 10357572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.